NuvOx Pharma Revenue and Competitors
Estimated Revenue & Valuation
- NuvOx Pharma's estimated annual revenue is currently $2.2M per year.
- NuvOx Pharma's estimated revenue per employee is $221,100
Employee Data
- NuvOx Pharma has 10 Employees.
- NuvOx Pharma grew their employee count by 11% last year.
NuvOx Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Operations Associate | Reveal Email/Phone |
NuvOx Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $22.3M | 108 | 17% | N/A | N/A |
#2 | $17.7M | 73 | 0% | N/A | N/A |
#3 | $6.6M | 33 | -8% | N/A | N/A |
#4 | $29.1M | 145 | 48% | N/A | N/A |
#5 | $1.2M | 6 | -50% | N/A | N/A |
#6 | $2.2M | 10 | 11% | N/A | N/A |
#7 | $4.8M | 19 | -5% | N/A | N/A |
#8 | $34.8M | 154 | 8% | N/A | N/A |
#9 | $46.2M | 221 | 16% | N/A | N/A |
#10 | $3.2M | 11 | -15% | N/A | N/A |
What Is NuvOx Pharma?
NuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a Phase IIa trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF). *Cover photo painting by Diane Fairfield
keywords:N/A
N/A
Total Funding
10
Number of Employees
$2.2M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NuvOx Pharma News
alliance pharma plc, baxter, NuvOx Pharma, Sanguine Biosciences, Therapure Biopharma Inc, Hemarina, Hemoglobin Oxygen Therapeutics,...
NuvOx Pharma's technology, which is developed as a first-in-class therapeutic to treat life-threatening diseases where hypoxia plays a role,...
NuvOx Pharma, a clinical stage biotechnology company developing a first-in-class therapeutic to treat life-threatening diseases where...
Other Companies in Tucson
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 10 | N/A | N/A |
#2 | $0.7M | 10 | 11% | N/A |
#3 | $0.5M | 10 | 43% | N/A |
#4 | $0.9M | 10 | -9% | N/A |
#5 | $1.2M | 10 | 67% | N/A |